Baino Francesco
Institute of Materials Physics and Engineering, Applied Science and Technology Department, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129, Torino, Italy.
J Biomed Mater Res A. 2015 Mar;103(3):1259-75. doi: 10.1002/jbm.a.35260. Epub 2014 Jun 18.
In the last few decades, the introduction of bioactive glasses (BGs), a special class of bioceramics that are able to bond to living tissues stimulating new tissue growth, has improved both treatment procedures via reconstructive surgery and the quality of life of rehabilitated patients in orthopedics and dentistry. While BGs have been extensively investigated for applications in these two surgical fields, there has been relatively little research on their use in other medical areas. Glass has been used for centuries to produce external refractive lenses and the intraocular implantation of small glass disks to correct visual deficiencies has been documented since the mid 1700s. Moreover, some evidences reported in the recent literature seem to demonstrate that the success of three specific types of ophthalmic devices, that is, synthetic grafts for eye orbit bone repair, orbital implants replacing the whole ocular globe and keratoprostheses (artificial cornea), could significantly benefit by the use of BG. A prospective view as well as a state-of-the-art review on this topic are currently lacking in the literature. The present article aims to give a comprehensive picture of the BG-based implants that have been developed in the context of ocular surgery; the strengths and shortcomings of the existing devices are outlined in order to provide useful stimuli for future research. Promising research directions are also proposed, emphasizing the added values that BGs could carry in ophthalmology in the light of recent findings in tissue engineering and regenerative medicine.
在过去几十年中,生物活性玻璃(BGs)的引入改善了整形外科手术的治疗程序以及骨科和牙科康复患者的生活质量。生物活性玻璃是一类特殊的生物陶瓷,能够与活组织结合,刺激新组织生长。虽然生物活性玻璃在这两个外科领域的应用已得到广泛研究,但在其他医学领域的应用研究相对较少。几个世纪以来,玻璃一直被用于制造外部屈光镜片,自18世纪中叶以来,就有关于植入小玻璃盘以矫正视力缺陷的文献记载。此外,最近文献报道的一些证据似乎表明,三种特定类型的眼科装置,即用于眼眶骨修复的合成移植物、替代整个眼球的眼眶植入物和角膜假体(人工角膜),使用生物活性玻璃可能会显著受益。目前文献中缺乏关于这一主题的前瞻性观点和最新综述。本文旨在全面介绍在眼科手术中开发的基于生物活性玻璃的植入物;概述现有装置的优缺点,以便为未来研究提供有益的启发。还提出了有前景的研究方向,根据组织工程和再生医学的最新发现,强调生物活性玻璃在眼科领域可能带来的附加值。